Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 72,456 | 50,959 | 37,837 | 27,482 | 24,215 |
| Cost of Goods | 6,572 | 4,139 | 3,289 | 3,278 | 3,550 |
| Gross Profit | 65,884 | 46,820 | 34,548 | 24,204 | 20,665 |
| Operating Expenses | 66,345 | 67,222 | 53,952 | 51,868 | 62,663 |
| Operating Income | 111 | -20,263 | -19,115 | -27,386 | -41,448 |
| Interest Expense | 4,887 | 4,185 | 3,772 | 3,373 | 4,132 |
| Other Income | -3,946 | -3,898 | -3,752 | -3,642 | -3,345 |
| Pre-tax Income | -8,722 | -28,346 | -26,639 | -34,401 | -48,925 |
| Income Tax | 5,629 | -4,772 | -275 | -1,054 | 1,015 |
| Net Income Continuous | -14,351 | -23,574 | -26,364 | -33,347 | -49,940 |
| Net Income | $-14,351 | $-23,574 | $-26,364 | $-33,347 | $-49,940 |
| EPS Basic Total Ops | -0.28 | -0.47 | -0.53 | -0.69 | -1.05 |
| EPS Basic Continuous Ops | -0.28 | -0.47 | -0.53 | -0.69 | -1.05 |
| EPS Diluted Total Ops | -0.28 | -0.47 | -0.53 | -0.69 | -1.05 |
| EPS Diluted Continuous Ops | -0.28 | -0.47 | -0.53 | -0.69 | -1.05 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.47 | -0.54 | -0.69 | -1.05 |
| EBITDA(a) | $163 | $-20,162 | $-19,115 | $-29,106 | $-40,594 |